La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Astellas Pharma Croissance future
Future contrôle des critères 3/6
Astellas Pharma is forecast to grow earnings and revenue by 29.5% and 1.1% per annum respectively. EPS is expected to grow by 29.8% per annum. Return on equity is forecast to be 12.7% in 3 years.
Informations clés
29.5%
Taux de croissance des bénéfices
29.8%
Taux de croissance du BPA
Pharmaceuticals croissance des bénéfices | 13.9% |
Taux de croissance des recettes | 1.1% |
Rendement futur des capitaux propres | 12.7% |
Couverture par les analystes | Good |
Dernière mise à jour | 19 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Aug 20Earnings Beat: Astellas Pharma Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 04Astellas Pharma's (TSE:4503) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 26Astellas Pharma (TSE:4503) Is Paying Out A Larger Dividend Than Last Year
Jul 11Is Astellas Pharma (TSE:4503) A Risky Investment?
Jun 14Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear
May 02Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 29Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price
Feb 29Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
3/31/2027 | 1,910,644 | 207,726 | 284,705 | 367,269 | 14 |
3/31/2026 | 1,797,257 | 146,217 | 286,038 | 356,273 | 15 |
3/31/2025 | 1,751,023 | 77,329 | 374,700 | 352,973 | 11 |
6/30/2024 | 1,701,806 | 21,519 | 92,795 | 172,877 | N/A |
3/31/2024 | 1,603,672 | 17,045 | 100,981 | 172,475 | N/A |
12/31/2023 | 1,543,324 | 4,198 | 136,404 | 216,089 | N/A |
9/30/2023 | 1,523,572 | 38,090 | 151,562 | 236,992 | N/A |
6/30/2023 | 1,511,818 | 107,031 | 205,852 | 291,133 | N/A |
3/31/2023 | 1,518,619 | 98,714 | 239,438 | 327,767 | N/A |
12/31/2022 | 1,468,235 | 136,430 | 183,399 | 260,759 | N/A |
9/30/2022 | 1,406,682 | 148,911 | 214,107 | 257,916 | N/A |
6/30/2022 | 1,351,811 | 118,211 | 215,849 | 266,193 | N/A |
3/31/2022 | 1,296,163 | 124,086 | 205,277 | 257,444 | N/A |
12/31/2021 | 1,300,914 | 120,167 | 236,959 | 290,559 | N/A |
9/30/2021 | 1,285,714 | 119,360 | 248,993 | 331,268 | N/A |
6/30/2021 | 1,268,702 | 100,863 | 261,235 | 325,326 | N/A |
3/31/2021 | 1,249,528 | 120,589 | 229,402 | 306,843 | N/A |
12/31/2020 | 1,253,215 | 138,307 | 196,679 | 276,851 | N/A |
9/30/2020 | 1,265,853 | 139,722 | 146,751 | 235,299 | N/A |
6/30/2020 | 1,273,678 | 187,306 | 135,534 | 236,186 | N/A |
3/31/2020 | 1,300,843 | 195,411 | 144,110 | 221,998 | N/A |
12/31/2019 | 1,289,855 | 220,751 | 151,021 | 225,239 | N/A |
9/30/2019 | 1,309,722 | 246,925 | 182,693 | 248,203 | N/A |
6/30/2019 | 1,311,397 | 226,224 | 176,251 | 228,863 | N/A |
3/31/2019 | 1,306,348 | 222,265 | 206,502 | 258,630 | N/A |
12/31/2018 | 1,305,901 | 213,600 | 254,876 | 300,955 | N/A |
9/30/2018 | 1,307,658 | 186,429 | 265,976 | 309,442 | N/A |
6/30/2018 | 1,306,830 | 176,770 | 246,040 | 290,301 | N/A |
3/31/2018 | 1,300,316 | 164,679 | N/A | 312,614 | N/A |
12/31/2017 | 1,305,521 | 182,515 | N/A | 264,549 | N/A |
9/30/2017 | 1,299,746 | 185,754 | N/A | 260,795 | N/A |
6/30/2017 | 1,296,484 | 194,556 | N/A | 276,954 | N/A |
3/31/2017 | 1,311,665 | 218,701 | N/A | 235,612 | N/A |
12/31/2016 | 1,312,627 | 207,940 | N/A | 325,459 | N/A |
9/30/2016 | 1,336,878 | 205,818 | N/A | 308,800 | N/A |
6/30/2016 | 1,366,799 | 215,678 | N/A | 302,245 | N/A |
3/31/2016 | 1,372,706 | 193,687 | N/A | 313,737 | N/A |
12/31/2015 | 1,360,153 | 185,659 | N/A | 207,806 | N/A |
9/30/2015 | 1,340,307 | 168,805 | N/A | 182,815 | N/A |
6/30/2015 | 1,295,761 | 144,617 | N/A | 156,675 | N/A |
3/31/2015 | 1,247,259 | 135,856 | N/A | 187,686 | N/A |
12/31/2014 | 1,205,276 | 124,154 | N/A | N/A | N/A |
9/30/2014 | 1,177,660 | 112,663 | N/A | 224,809 | N/A |
6/30/2014 | 1,159,218 | 104,614 | N/A | N/A | N/A |
3/31/2014 | 1,139,909 | 90,874 | N/A | 214,257 | N/A |
12/31/2013 | 1,137,824 | 79,679 | N/A | N/A | N/A |
9/30/2013 | 1,085,481 | 73,641 | N/A | 183,507 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 4503's forecast earnings growth (29.5% per year) is above the savings rate (0.3%).
Bénéfices vs marché: 4503's earnings (29.5% per year) are forecast to grow faster than the JP market (8.5% per year).
Croissance élevée des bénéfices: 4503's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 4503's revenue (1.1% per year) is forecast to grow slower than the JP market (4.3% per year).
Croissance élevée des revenus: 4503's revenue (1.1% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 4503's Return on Equity is forecast to be low in 3 years time (12.7%).